International journal of surgery (London, England) · 2025
Dynamic frailty trajectories identify thymoma patients at high risk of postoperative muscle weakness.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wang Ziming, Wang Yuming, Yan Liancai, Yang Fugui, Tao Bo, Zhu Lei
Аннотация
BACKGROUND: Thymoma is the most common anterior mediastinal tumor and poses significant postoperative challenges, including muscle weakness. Frailty is a multidimensional syndrome linked to poor surgical outcomes and remains understudied in thymoma. This study investigates the impact of preoperative frailty and its dynamic trajectories on postoperative muscle weakness.
METHODS: A retrospective cohort of 531 thymoma patients (2015-2025) was recruited. Frailty was assessed pre- and postoperatively using the Rockwood Frailty Index (FI), categorized as robust (FI ≤ 0.10), pre-frail (0.10 < FI < 0.25), or frail (FI ≥ 0.25). Postoperative muscle weakness was defined as ≥1 MRC grade decline. Cox regression models adjusted for demographics, comorbidities, and laboratory parameters evaluated associations between frailty status, ΔFI (change in FI), and outcomes.
RESULTS: Among 405 analyzed patients, pre-frail (HR = 1.70, 95%CI: 1.38-2.02) and frail (HR = 1.83, 95%CI: 1.51-2.15) individuals had significantly higher muscle weakness risks versus robust. Frailty progression (ΔFI increase) raised risk by 41% (HR = 1.41, 95%CI: 1.22-1.60), while recovery reduced it by 31% (HR = 0.69, 95%CI: 0.58-0.81). Cumulative FI (upper tertile HR = 2.85, 95%CI: 2.64-3.03) and ΔFI (upper tertile HR = 1.83, 95%CI: 1.69-1.97) exhibited dose-dependent associations with adverse outcomes (trend P < 0.01).
CONCLUSION: Preoperative frailty and its dynamic changes independently are associated with postoperative muscle weakness in thymoma patients. The Rockwood FI provides prognostic value for risk stratification, highlighting the pre-frail state as a modifiable target for prehabilitation. Integrating longitudinal frailty assessments into perioperative care may optimize recovery and survival, urging future trials to validate disease-specific thresholds and interventions.
METHODS: A retrospective cohort of 531 thymoma patients (2015-2025) was recruited. Frailty was assessed pre- and postoperatively using the Rockwood Frailty Index (FI), categorized as robust (FI ≤ 0.10), pre-frail (0.10 < FI < 0.25), or frail (FI ≥ 0.25). Postoperative muscle weakness was defined as ≥1 MRC grade decline. Cox regression models adjusted for demographics, comorbidities, and laboratory parameters evaluated associations between frailty status, ΔFI (change in FI), and outcomes.
RESULTS: Among 405 analyzed patients, pre-frail (HR = 1.70, 95%CI: 1.38-2.02) and frail (HR = 1.83, 95%CI: 1.51-2.15) individuals had significantly higher muscle weakness risks versus robust. Frailty progression (ΔFI increase) raised risk by 41% (HR = 1.41, 95%CI: 1.22-1.60), while recovery reduced it by 31% (HR = 0.69, 95%CI: 0.58-0.81). Cumulative FI (upper tertile HR = 2.85, 95%CI: 2.64-3.03) and ΔFI (upper tertile HR = 1.83, 95%CI: 1.69-1.97) exhibited dose-dependent associations with adverse outcomes (trend P < 0.01).
CONCLUSION: Preoperative frailty and its dynamic changes independently are associated with postoperative muscle weakness in thymoma patients. The Rockwood FI provides prognostic value for risk stratification, highlighting the pre-frail state as a modifiable target for prehabilitation. Integrating longitudinal frailty assessments into perioperative care may optimize recovery and survival, urging future trials to validate disease-specific thresholds and interventions.